Effect of advanced glycosylation end products on apoptosis in human adipose tissue-derived stem cells in vitro

Cell and Bioscience

Volumn 5, Issue 1, 2015, Pages

  Wang, Zhe ^a   Li, Hongqiu ^a,b   Zhang, Dianbao ^a   Liu, Xiaoyu ^a   Zhao, Feng ^a   Pang, Xining ^a   Wang, Qiushi ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b SHENYANG MEDICAL COLLEGE   (China)

Author keywords

Advanced glycation end products; Apoptosis; Human adipose tissue derived stem cells; Mitogen activated protein kinase; Receptor for advanced glycation end products

Indexed keywords

EID: 85027943969     PISSN: None     EISSN: 20453701     Source Type: Journal    
DOI: 10.1186/2045-3701-5-3     Document Type: Article

References (35)

1. Del Turco S, Basta G: An update on advanced glycation endproducts and atherosclerosis. Biofactors 2012, 38:266-74. 10.1002/biof.1018
2. Vlassara H, Uribarri J: Advanced Glycation End Products (AGE) and diabetes: cause, effect, or both? Curr Diab Rep 2014, 14:1-10.
3. Forbes JM, Sourris KC, de Courten MP, Dougherty SL, Chand V, Lyons JG, et al.: Advanced glycation end products (AGEs) are cross-sectionally associated with insulin secretion in healthy subjects. Amino Acids 2014, 46:321-6. 10.1007/s00726-013-1542-9
4. Kim S, Kwon J: COMP-Ang1 inhibits apoptosis as well as improves the attenuated osteogenic differentiation of mesenchymal stem cells induced by advanced glycation end products. Biochim Biophys Acta 1830, 2013:4928-34.
5. Ishibashi Y, Yamagishi S, Matsui T, Ohta K, Tanoue R, Takeuchi M, et al.: Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level. Metabolism 2012, 61:1067-72. 10.1016/j.metabol.2012.01.006
6. Barlovic DP, Thomas MC, Jandeleit-Dahm K: Cardiovascular Disease: Whats All the AGE/RAGE About? Cardiovasc Haematological Dis-Drug Targets 2010, 10:7-15. 10.2174/187152910790780050
7. Monnier VM, Sun W, Sell DR, Fan X, Nemet I, Genuth S: Glucosepane: a poorly understood advanced glycation end product of growing importance for diabetes and its complications. Clin Chem Lab Med 2014, 52:21-32.
8. Vlassara H, Striker GE: Advanced glycation endproducts in diabetes and diabetic complications. Endocrinol Metab Clin North Am 2013, 42:697-719. 10.1016/j.ecl.2013.07.005
9. Pan Y, Liang H, Liu H, Li D, Chen X, Li L, et al.: Platelet-secreted MicroRNA-223 promotes endothelial cell apoptosis induced by advanced glycation End products via targeting the insulin-like growth factor 1 receptor. J Immunol 2014, 192:437-46. 10.4049/jimmunol.1301790
10. Shi L, Yu X, Yang H, Wu X: Advanced glycation end products induce human corneal epithelial cells apoptosis through generation of reactive oxygen species and activation of jnk and p38 mapk pathways. PLoS One 2013, 8:e66781. 10.1371/journal.pone.0066781
11. Lien SC, Chang SF, Lee PL, Wei SY, Chang MD, Chang JY, et al.: Mechanical regulation of cancer cell apoptosis and autophagy: Roles of bone morphogenetic protein receptor, Smad1/5, and p38 MAPK. Biochim Biophys Acta 2013, 1833:3124-33. 10.1016/j.bbamcr.2013.08.023
12. Zhang W, Lan Y, Huang Q, Hua Z: Galangin induces B16F10 melanoma cell apoptosis via mitochondrial pathway and sustained activation of p38 MAPK. Cytotechnology 2013, 65:447-55. 10.1007/s10616-012-9499-1
13. Yin Y, Liu W, Ji G, Dai Y: The essential role of p38 MAPK in mediating the interplay of oxLDL and IL-10 in regulating endothelial cell apoptosis. Eur J Cell Biol 2013, 92:150-9. 10.1016/j.ejcb.2013.01.001
14. Zheng F, Tang Q, Wu J, Zhao S, Liang Z, Li L, et al.: p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine. J Exp Clin Cancer Res 2014, 33:1-12. 10.1186/1756-9966-33-1
15. Hsu WH, Hsieh YS, Kuo HC, Teng CY, Huang HI, Wang CJ, et al.: Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL. Arch Toxicol 2007, 81:719-28. 10.1007/s00204-006-0169-y
16. Alikhani M, Maclellan CM, Raptis M, Vora S, Trackman PC, Graves DT: Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor. Am J Physiol Cell Physiol 2007, 292:C850-6.
17. Gangoiti MV, Cortizo AM, Arnol V, Felice JI, McCarthy AD: Opposing effects of bisphosphonates and advanced glycation end-products on osteoblastic cells. Eur J Pharmacol 2008, 600:140-7. 10.1016/j.ejphar.2008.10.031
18. Sun C, Liang C, Ren Y, Zhen Y, He Z, Wang H, et al.: Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways. Basic Res Cardiol 2009, 104:42-9. 10.1007/s00395-008-0738-8
19. Yao D, Brownlee M: Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands. Diabetes 2010, 59:249-55. 10.2337/db09-0801
20. Yamagishi S: Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes. Exp Gerontol 2011, 46:217-24. 10.1016/j.exger.2010.11.007
21. Xie J, Méndez JD, Méndez-Valenzuela V, Aguilar-Hernández MM: Cellular signalling of the receptor for advanced glycation end products (RAGE). Cell Signal 2013, 25:2185-97. 10.1016/j.cellsig.2013.06.013
22. Chen J, Song M, Yu S, Gao P, Yu Y, Wang H, et al.: Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overpression of cell oxidant stress. Mol Cell Biochem 2010, 335:137-46. 10.1007/s11010-009-0250-y
23. Sun N, Yang L, Li Y, Zhang H, Chen H, Liu D, et al.: Effect of advanced oxidation protein products on the proliferation and osteogenic differentiation of rat mesenchymal stem cells. Int J Mol Med 2013, 32:485-91.
24. Liu X, Wang Z, Wang R, Zhao F, Shi P, Jiang Y, et al.: Direct comparison of the potency of human mesenchymal stem cells derived from amnion tissue, bone marrow and adipose tissue at inducing dermal fibroblast responses to cutaneous wounds. Int J Mol Med 2013, 31:407-15.
25. Strioga M, Viswanathan S, Darinskas A, Slaby O, Michalek J: Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev 2012, 21:2724-52. 10.1089/scd.2011.0722
26. Saki N, Jalalifar MA, Soleimani M, Hajizamani S, Rahim F: Adverse effect of high glucose concentration on stem cell therapy. Int J Hematol Oncol Stem Cell Res 2013, 7:34-40.
27. Alikhani M, Alikhani Z, Boyd C, MacLellan CM, Raptis M, Liu R, et al.: Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways. Bone 2007, 40:345-53. 10.1016/j.bone.2006.09.011
28. Cianfarani F, Toietta G, Di Rocco G, Cesareo E, Zambruno G, Odorisio T: Diabetes impairs adipose tissue-derived stem cell function and efficiency in promoting wound healing. Wound Repair Regen 2013, 21:545-53. 10.1111/wrr.12051
29. Locke M, Feisst V, Dunbar P: Human adipose-derived stem cells: separating promise from clinical need. Stem Cells 2011, 29:404-11. 10.1002/stem.593
30. Jin HJ, Bae YK, Kim M, Kwon SJ, Jeon HB, Choi SJ, et al.: Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. Int J Mol Sci 2013, 14:17986-8001. 10.3390/ijms140917986
31. Al-Nbaheen M, Vishnubalaji R, Ali D, Bouslimi A, Al-Jassir F, Megges M, et al.: Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential. Stem Cell Rev Rep 2013, 9:32-43. 10.1007/s12015-012-9365-8
32. Stirban A, Gawlowski T, Roden M: Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms. Mol Metab 2013, 3:94-108.
33. Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF, Schmidt AM: Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 2005, 15:16R-28. 10.1093/glycob/cwi053
34. Zong H, Ward M, Stitt AW: AGEs, RAGE, and diabetic retinopathy. Curr Diab Rep 2011, 11:244-52. 10.1007/s11892-011-0198-7
35. Chen Q, Dong L, Wang L, Kang L, Xu B: Advanced glycation end products impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2. Bioche Biopphy Res Commun 2009, 381:192-7. 10.1016/j.bbrc.2009.02.040